AXT 경영진
경영진 기준 점검 3/4
AXT CEO는 Morris Young, Jan1986 에 임명되었습니다 의 임기는 40.33 년입니다. 총 연간 보상은 $1.67M, 28.6% 급여 및 71.4% 보너스(회사 주식 및 옵션 포함)로 구성됩니다. 는 $256.03M 가치에 해당하는 회사 주식의 3.46% 직접 소유합니다. 경영진과 이사회의 평균 재임 기간은 11.8 년과 26.8 년입니다.
핵심 정보
Morris Young
최고경영자
US$1.7m
총 보수
| CEO 급여 비율 | 28.62% |
| CEO 재임 기간 | 40.3yrs |
| CEO 지분 보유율 | 3.5% |
| 경영진 평균 재임 기간 | 11.8yrs |
| 이사회 평균 재임 기간 | 26.8yrs |
최근 경영진 업데이트
Recent updates
Seeking Alpha • May 04
AXT Inc. Hits New All-Time Highs On Strong Earnings And Forward Outlook
Summary AXT, Inc. delivered strong Q1-2026 results driven by high demand for Indium Phosphide. AXT plans to expand its Indium Phosphide capacity over the next two years. The AXT stock price has gained 7,000% over the last year and is now extremely overvalued. I continue my rating of a hold for AXT stock. Read the full article on Seeking Alpha
내러티브 업데이트 • Apr 29
AXTI: Future InP Substrate Demand Will Outweigh Near Term Export Constraints
Narrative Update on AXT The analyst price target for AXT has moved from $45 to $90, with analysts pointing to higher assumed profit margins, an increased future P/E multiple, and stronger long term InP substrate demand expectations supported by recent capacity and capex plans at major optical and cloud players. Analyst Commentary Recent Street research on AXT highlights a mix of optimism on long term InP substrate demand and some short term caution around export related constraints.
내러티브 업데이트 • Apr 14
AXTI: Export Permit Limits Will Continue To Restrain InP AI Upside
Analysts have raised AXT's fair value estimate from $28.25 to $30.75, reflecting updated views on higher potential P/E multiples, supported by expected InP growth and recent price target increases from several research firms. Analyst Commentary Recent research gives you a mixed but useful read on how the Street is thinking about AXT, with some focusing on long term InP growth potential and others highlighting nearer term execution risks and regulatory overhangs.내러티브 업데이트 • Mar 31
AXTI: Export Permit Constraints Will Limit Upside Despite InP Demand Story
AXT's analyst fair value estimate has been raised from $26.00 to $45.00 as analysts factor in expectations for higher revenue, stronger profit margins, and a richer forward P/E multiple supported by rising Street price targets related to InP demand and export permit clarity. Analyst Commentary Recent research on AXT points to a split view, with some caution around near term export permit issues, but also a series of more optimistic calls that connect the story to longer term compound semiconductor demand and valuation support tied to InP exposure.
내러티브 업데이트 • Mar 17
AXTI: Export Permit Constraints Will Limit Benefit Of InP Demand Optimism
The analyst price target for AXT has increased from $8.50 to $21, with analysts citing stronger InP growth expectations, higher projected profit margins, and a higher assumed future P/E multiple as key supports for the updated valuation framework. Analyst Commentary Recent Street research on AXT reflects a wide spread in price targets, with some analysts using relatively high P/E multiples based on long term InP growth expectations and others taking a more cautious stance as they weigh near term execution risks and policy related constraints.내러티브 업데이트 • Mar 03
AXTI: InP Export Permit Constraints Will Undermine AI Demand Upside Potential
Narrative Update on AXT The analyst price targets for AXT have moved sharply higher, with recent updates ranging from $21 to $35. Analysts are factoring in higher fair value estimates and stronger InP growth expectations, despite ongoing export permit uncertainty.내러티브 업데이트 • Feb 17
AXTI: Neutral Stance Will Reflect Export Permit Risks And Equity Raise
Narrative Update on AXT Price Target Analysts have raised their AXT price target from $9 to $18, citing updated assumptions for higher revenue growth and profit margins, as well as a lower discount rate. At the same time, they have shifted to a Neutral stance following export permit related headwinds in InP substrate shipments.내러티브 업데이트 • Feb 03
AXTI: Export Permit Constraints And Equity Offering Will Pressure Future Returns
Analysts have raised their price target on AXT to US$18 from US$9, citing valuation after the company adjusted its Q4 revenue outlook due to fewer export permits for InP substrates from the Chinese government. Analyst Commentary Bearish analysts are framing the new US$18 price target as less about improving fundamentals and more about the stock having already run ahead of what they see as reasonable expectations.내러티브 업데이트 • Jan 20
AXTI: Export Permit Uncertainty Will Constrain Near Term Revenue Outlook
Analysts have lifted their price targets for AXT, with moves such as from US$4.10 to US$7 and from US$9 to US$18, citing changing views on export permit progress, revenue assumptions, and valuation. Analyst Commentary Recent Street research on AXT reflects a mixed backdrop, with some bearish analysts turning more cautious even as price targets move higher.내러티브 업데이트 • Jan 05
AXTI: Export Permits Will Drive Fragile Near Term Revenue Expectations
Analysts lifted their price target on AXT to $7.00 from $4.10, pointing to updated Q3 revenue assumptions after the company received export permits from China's Ministry of Commerce to resume shipping indium phosphide substrates to additional customers. Analyst Commentary Analysts point to the new export permits as a key reason for revisiting their models, with Q3 revenue assumptions adjusted to reflect the potential contribution from indium phosphide substrate shipments to additional customers.분석 기사 • Dec 19
AXT, Inc.'s (NASDAQ:AXTI) 39% Share Price Surge Not Quite Adding Up
AXT, Inc. ( NASDAQ:AXTI ) shares have continued their recent momentum with a 39% gain in the last month alone. The last...내러티브 업데이트 • Dec 14
AXTI: New Export Permits Will Intensify Regulatory And Execution Downside Risks
Analysts have raised their price target on AXT by approximately $2.90 per share to around $7.00, citing improved revenue expectations after the company received new export permits that enable it to resume shipping indium phosphide substrates to additional customers. Analyst Commentary Analysts are updating their models ahead of upcoming quarterly results, reflecting the impact of newly granted export permits on AXT's near term revenue and margin profile.내러티브 업데이트 • Nov 30
AXTI: Export Permit Reliance Will Heighten Downside Risks Amid Ongoing Uncertainty
Analysts have increased their price target for AXT to $7 from $4.10, citing higher anticipated revenues because the company recently obtained export permits that allow it to ship indium phosphide substrates to additional customers. Analyst Commentary Recent updates from the analyst community reflect a reassessment of AXT's growth prospects and financial outlook following the news about new export permits for indium phosphide substrates.내러티브 업데이트 • Nov 16
AXTI: Renewed Export Permits Will Influence Recovery Amid Regulatory Risks
Analysts have raised AXT's fair value estimate significantly from $5.70 to $9.50 per share, citing improved revenue assumptions following renewed export permits and a higher price target in recent research updates. Analyst Commentary Analyst reactions to AXT's recent developments have brought both optimism and caution regarding the company's future prospects and valuation.내러티브 업데이트 • Nov 02
AXTI: Export Permit Uncertainty Will Challenge Margin Strength Moving Forward
The analyst price target for AXT has increased significantly from $3.82 to $5.70 per share, as analysts cite improved revenue growth expectations and recent export permit approvals as key drivers behind their revised outlook. Analyst Commentary Analyst sentiment regarding AXT has evolved in response to recent company developments, with notable optimism about future growth prospects.분석 기사 • Oct 14
AXT, Inc. (NASDAQ:AXTI) Shares Fly 26% But Investors Aren't Buying For Growth
AXT, Inc. ( NASDAQ:AXTI ) shares have continued their recent momentum with a 26% gain in the last month alone. Looking...분석 기사 • Oct 08
Here's Why AXT (NASDAQ:AXTI) Can Afford Some Debt
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...분석 기사 • Jul 20
AXT, Inc. (NASDAQ:AXTI) Stock Catapults 33% Though Its Price And Business Still Lag The Industry
Despite an already strong run, AXT, Inc. ( NASDAQ:AXTI ) shares have been powering on, with a gain of 33% in the last...
새 내러티브 • May 02
Chinese Data Center Demand And Laser Tech Will Open New Markets
Strategic positioning in the Chinese data center market and local sourcing aims to reduce foreign dependency and boost revenue growth.Seeking Alpha • Feb 24
AXT, Inc. Reported Improved Q4 Financial Performance But Q1 Outlook Disappoints
Summary AXT, Inc. reported increased revenues QoQ and YoY due to higher demand for its indium phosphide wafers. The company expects lower Q1 2025 revenues due to new regulations in China over exports of indium phosphide. The company’s stock price hit its 52-week low last Friday due to the weak Q1 outlook. The company still foresees strong performance during 2025 and 2026 regardless of the setback. I rate AXTI stock as a Hold for now and recommend that investors watch the company for developments. Read the full article on Seeking AlphaSeeking Alpha • Oct 26
AXT, Inc.: Not Getting The Recognition It Deserves
Summary AXT, Inc. came close to multi-year lows last September after a selloff following guidance, but history suggests that might have been a good entry point. Guidance suggests AXTI will grow slower, at least in the short term, but there is nonetheless much more to remain upbeat about. There have been setbacks, including in terms of AI, but AXTI is still growing and on pace to get back to earning a profit as soon as next year. It may take some time and patience, but long AXTI still looks like it has what it takes to become a winning play. Read the full article on Seeking AlphaSeeking Alpha • Aug 05
AXT, Inc.: Downgrading On Limited Visibility And Early Cracks In The AI Story
Summary Semiconductor substrate provider AXT, Inc. reported better-than-expected Q2/2024 results, with both revenues and profitability coming in ahead of consensus estimates. Strong sequential growth in gallium arsenide and germanium substrate sales were partially offset by a decrease in indium phosphide revenues. However, Q3 guidance came in below consensus expectations due to an anticipated sequential decline in substrate revenues. While the company looks cheap following Friday's selloff, limited visibility and a rather lumpy AI revenue ramp are likely to keep the stock in the penalty box for at least the next couple of months. Given these issues, I am downgrading the company's stock from "Buy" to "Hold". Read the full article on Seeking AlphaSeeking Alpha • Jul 21
AXT Inc.: Playing An Expected Rebound
Summary The stock has sold off in the last three days due to AXTI’s ties to China, but this could be an opportunity to take advantage of. AXTI is valued at much less than book value, which could become untenable if AXTI gets out of the red in 2025. AXTI is scheduled to release the Q2 report on August 1 and the conditions are there for a repeat of what happened twice before in 2024. The China factor will not go away anytime soon, but long AXTI has enough in its favor to make it worth backing. Read the full article on Seeking AlphaSeeking Alpha • May 07
AXT: Strong Outlook As Business Recovery Is Picking Up Steam - Buy
Summary Semiconductor substrate provider AXT, Inc. reported Q1/2024 results in line with its April 8 preannouncement and provided Q2 guidance well ahead of expectations. The company's substrate business continues to recover across all major product lines, with some AI-related demand contributing to a 50% sequential increase in indium phosphide sales. Management expects the company to reach breakeven levels by the end of this year or early next year. The company is considering monetizing some of its holdings in a number of Chinese raw materials providers. Risk/reward is looking increasingly favorable for speculative investors, with the business recovering across the board and a number of potential near- and medium-term catalysts. Reiterating "Buy" rating with a near-term price target of $5.30. Read the full article on Seeking AlphaSeeking Alpha • Apr 05
AXT: Selloff Provides Buying Opportunity
Summary A plethora of allegations raised in a new shortseller report caused AXT, Inc.'s shares to crater by 35%. The core short thesis is centering around the risks resulting from a potential failure to list Chinese subsidiary Tongmei on the Shanghai Star Market. However, these risks have been adequately disclosed by the company in recent years and should be well-known among market participants following AXT more closely. In addition, the company's business is showing early signs of life after a couple of abysmal quarters with analysts projecting a full-blown recovery for next year. In my opinion, Thursday's selloff provides speculative investors an opportunity to initiate positions in a recovering business driven by exposure to the red hot data center and AI market. Should AXT execute at least in line with current analyst expectations, the stock might approach $6 next year. Read the full article on Seeking AlphaCEO 보수 분석
| 날짜 | 총 보수 | 급여 | 회사 수익 |
|---|---|---|---|
| Mar 31 2026 | n/a | n/a | -US$14m |
| Dec 31 2025 | US$2m | US$479k | -US$21m |
| Sep 30 2025 | n/a | n/a | -US$23m |
| Jun 30 2025 | n/a | n/a | -US$24m |
| Mar 31 2025 | n/a | n/a | -US$19m |
| Dec 31 2024 | US$1m | US$479k | -US$12m |
| Sep 30 2024 | n/a | n/a | -US$10m |
| Jun 30 2024 | n/a | n/a | -US$13m |
| Mar 31 2024 | n/a | n/a | -US$17m |
| Dec 31 2023 | US$738k | US$479k | -US$18m |
| Sep 30 2023 | n/a | n/a | -US$13m |
| Jun 30 2023 | n/a | n/a | -US$2m |
| Mar 31 2023 | n/a | n/a | US$9m |
| Dec 31 2022 | US$1m | US$479k | US$16m |
| Sep 30 2022 | n/a | n/a | US$17m |
| Jun 30 2022 | n/a | n/a | US$15m |
| Mar 31 2022 | n/a | n/a | US$14m |
| Dec 31 2021 | US$3m | US$445k | US$14m |
| Sep 30 2021 | n/a | n/a | US$13m |
| Jun 30 2021 | n/a | n/a | US$11m |
| Mar 31 2021 | n/a | n/a | US$7m |
| Dec 31 2020 | US$1m | US$445k | US$3m |
| Sep 30 2020 | n/a | n/a | -US$1m |
| Jun 30 2020 | n/a | n/a | -US$3m |
| Mar 31 2020 | n/a | n/a | -US$2m |
| Dec 31 2019 | US$2m | US$445k | -US$3m |
보상 대 시장: Morris의 총 보수(USD1.67M)는 US 시장에서 비슷한 규모 기업의 평균(USD8.41M)보다 낮습니다.
보상과 수익: Morris의 보상은 회사가 적자임에도 증가했습니다.
CEO
Morris Young (80 yo)
40.3yrs
재임 기간
US$1,673,404
보수
Dr. Morris S. Young, Ph D., Co-founded AXT Inc. in 1986, has been its Chief Executive Officer since July 16, 2009, its Chairman since August 12, 2021 and its Director since 1989. Dr. Young served as an Int...
리더십 팀
| 이름 | 직위 | 재임 기간 | 보수 | 지분 |
|---|---|---|---|---|
| Co-Founder | 40.3yrs | US$1.67m | 3.46% $ 256.0m | |
| CFO, VP & Corporate Secretary | 11.8yrs | US$839.53k | 0.29% $ 21.7m | |
| Chief Technical Officer | 7yrs | 데이터 없음 | 데이터 없음 | |
| Vice President of Business Development | no data | 데이터 없음 | 데이터 없음 |
11.8yrs
평균 재임 기간
경험이 풍부한 관리: AXTI의 경영진은 노련하고 경험이 풍부합니다(평균 재임 11.8 년).
이사회 구성원
| 이름 | 직위 | 재임 기간 | 보수 | 지분 |
|---|---|---|---|---|
| Co-Founder | 37.3yrs | US$1.67m | 3.46% $ 256.0m | |
| Independent Director | 25.4yrs | US$158.00k | 0.11% $ 8.2m | |
| Lead Independent Director | 28.3yrs | US$168.30k | 0.17% $ 12.4m | |
| Independent Director | less than a year | US$66.67k | 0.18% $ 13.5m |
26.8yrs
평균 재임 기간
81.5yo
평균 나이
경험이 풍부한 이사회: AXTI의 이사회는 노련하고 경험이 풍부합니다(평균 재임 26.8 년).
기업 분석 및 재무 데이터 상태
| 데이터 | 최종 업데이트 (UTC 시간) |
|---|---|
| 기업 분석 | 2026/05/11 16:15 |
| 종가 | 2026/05/11 00:00 |
| 수익 | 2026/03/31 |
| 연간 수익 | 2025/12/31 |
데이터 소스
당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.
| 패키지 | 데이터 | 기간 | 미국 소스 예시 * |
|---|---|---|---|
| 기업 재무제표 | 10년 |
| |
| 분석가 컨센서스 추정치 | +3년 |
|
|
| 시장 가격 | 30년 |
| |
| 지분 구조 | 10년 |
| |
| 경영진 | 10년 |
| |
| 주요 개발 | 10년 |
|
* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.
별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.
분석 모델 및 스노우플레이크
이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.
Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.
산업 및 섹터 지표
산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.
분석가 소스
AXT, Inc.는 7명의 분석가가 다루고 있습니다. 이 중 5명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
| 분석가 | 기관 |
|---|---|
| Ku Kang | B. Riley Securities, Inc. |
| Hamed Khorsand | BWS Financial Inc. |
| Richard Shannon | Craig-Hallum Capital Group LLC |